Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

“Short term share price behavior is totally different thing. A failure in primary measure regardless what happens in secondary measure would probably tank SP for a duration.”

Actually, sounds like we agree.

Furthermore, I never claimed that a trial that failed to meet its primary endpoints could’t ultimately receive fda approval based on secondary endpoints. I only wrote that a trial failure would be devastating for ipix.